Published 12 issues per year
ISSN Print: 1521-9437
ISSN Online: 1940-4344
Indexed in
Anti-Inflammation and Lipogenic Inhibition of Taiwanofungus salmonea Mycelium and Grifola frondosa Fruiting Body
ABSTRACT
A long-term inflammatory response can cause the development of nonalcoholic steatohepatitis (NASH), which is mainly caused by abnormal metabolism of lipids in the liver. Taiwanofungus salmonea and Grifola frondosa, which are valuable medicinal mushrooms in Taiwan and exhibit many beneficial bioactivities, are used to evaluate effects on immune regulation in Raw 264.7 cells and on NASH-related responses in Hep G2 cells. According to the results, the production of proinflammatory cytokines was effectively decreased, whereas the production of interleukin-10 was increased. Lipid accumulation and reactive oxygen species production also declined, and free glycerol was released. The expression of acetyl-CoA carboxylase, fatty acid synthase, and sterol regulatory element-binding protein 1c was decreased. These results indicate that T. salmonea and G. frondosa are capable of reducing inflammatory responses and ameliorating NASH, indicating their potential as hepatoprotective dietary supplements.
-
Zhang Weiwei, Jiang Xuezhen, Zhao Shuang, Zheng Xiaojie, Lan Jin, Wang Hexiang, Ng Tzi Bun, A polysaccharide-peptide with mercury clearance activity from dried fruiting bodies of maitake mushroom Grifola frondosa, Scientific Reports, 8, 1, 2018. Crossref
-
Qu Xinyan, Li Qingjun, Song Yue, Xue Anqi, Liu Yuhua, Qi Dongmei, Dong Hongjing, Potential of myricetin to restore the immune balance in dextran sulfate sodium-induced acute murine ulcerative colitis, Journal of Pharmacy and Pharmacology, 72, 1, 2019. Crossref
-
Hyde Kevin D., Xu Jianchu, Rapior Sylvie, Jeewon Rajesh, Lumyong Saisamorn, Niego Allen Grace T., Abeywickrama Pranami D., Aluthmuhandiram Janith V. S., Brahamanage Rashika S., Brooks Siraprapa, Chaiyasen Amornrat, Chethana K. W. Thilini, Chomnunti Putarak, Chepkirui Clara, Chuankid Boontiya, de Silva Nimali I., Doilom Mingkwan, Faulds Craig, Gentekaki Eleni, Gopalan Venkat, Kakumyan Pattana, Harishchandra Dulanjalee, Hemachandran Hridya, Hongsanan Sinang, Karunarathna Anuruddha, Karunarathna Samantha C., Khan Sehroon, Kumla Jaturong, Jayawardena Ruvishika S., Liu Jian-Kui, Liu Ningguo, Luangharn Thatsanee, Macabeo Allan Patrick G., Marasinghe Diana S., Meeks Dan, Mortimer Peter E., Mueller Peter, Nadir Sadia, Nataraja Karaba N., Nontachaiyapoom Sureeporn, O’Brien Meghan, Penkhrue Watsana, Phukhamsakda Chayanard, Ramanan Uma Shaanker, Rathnayaka Achala R., Sadaba Resurreccion B., Sandargo Birthe, Samarakoon Binu C., Tennakoon Danushka S., Siva Ramamoorthy, Sriprom Wasan, Suryanarayanan T. S., Sujarit Kanaporn, Suwannarach Nakarin, Suwunwong Thitipone, Thongbai Benjarong, Thongklang Naritsada, Wei Deping, Wijesinghe S. Nuwanthika, Winiski Jake, Yan Jiye, Yasanthika Erandi, Stadler Marc, The amazing potential of fungi: 50 ways we can exploit fungi industrially, Fungal Diversity, 97, 1, 2019. Crossref
-
Chitra J., Rajendren S., Jeyakanthan J., Gopal Samy B., Jeba Mercy J., Manikandan N., Prasanna Kumari N.K., Microbes and their products as novel therapeutics in medical applications, in Bioprospecting of Microbial Diversity, 2022. Crossref